{"title":"Still invisible? Legal and ethical treatment of intersex individuals in China.","authors":"Meng Wang, Yann Joly","doi":"10.1093/jlb/lsag018","DOIUrl":null,"url":null,"abstract":"<p><p>This article explores the legal, social, and ethical challenges faced by intersex individuals in China, a population estimated to number in the millions but still largely invisible in national laws and public discourse. Drawing on recent international human rights developments and comparative legal analysis, the paper critically examines China's legal and medical frameworks through the lens of intersex rights. It highlights how entrenched binary conceptions of sex and gender deeply rooted in Confucian traditions, and reflected in Chinese administrative, medical, and legal systems, lead to widespread discrimination, non-consensual medical interventions, and structural exclusion of intersex individuals. The authors argue that despite generic constitutional and civil guarantees of equality, bodily integrity, and informed consent, intersex persons remain insufficiently protected due to the absence of targeted legislation and interpretive guidance. The article proposes incremental yet concrete reforms such as deferring non-urgent medical interventions, improving psychosocial support, introducing neutral terminology, and developing best-practice medical guidelines as viable steps toward greater inclusion. By examining relevant international and regional practices, including developments in Malta, Australia, and Hong Kong, the paper advocates for a post-binary legal approach that affirms intersex individuals' dignity, autonomy, and right to recognition in Chinese law and society.</p>","PeriodicalId":56266,"journal":{"name":"Journal of Law and the Biosciences","volume":"13 1","pages":"lsag018"},"PeriodicalIF":3.4000,"publicationDate":"2026-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13235709/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Law and the Biosciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jlb/lsag018","RegionNum":2,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"ETHICS","Score":null,"Total":0}
引用次数: 0
Abstract
This article explores the legal, social, and ethical challenges faced by intersex individuals in China, a population estimated to number in the millions but still largely invisible in national laws and public discourse. Drawing on recent international human rights developments and comparative legal analysis, the paper critically examines China's legal and medical frameworks through the lens of intersex rights. It highlights how entrenched binary conceptions of sex and gender deeply rooted in Confucian traditions, and reflected in Chinese administrative, medical, and legal systems, lead to widespread discrimination, non-consensual medical interventions, and structural exclusion of intersex individuals. The authors argue that despite generic constitutional and civil guarantees of equality, bodily integrity, and informed consent, intersex persons remain insufficiently protected due to the absence of targeted legislation and interpretive guidance. The article proposes incremental yet concrete reforms such as deferring non-urgent medical interventions, improving psychosocial support, introducing neutral terminology, and developing best-practice medical guidelines as viable steps toward greater inclusion. By examining relevant international and regional practices, including developments in Malta, Australia, and Hong Kong, the paper advocates for a post-binary legal approach that affirms intersex individuals' dignity, autonomy, and right to recognition in Chinese law and society.
期刊介绍:
The Journal of Law and the Biosciences (JLB) is the first fully Open Access peer-reviewed legal journal focused on the advances at the intersection of law and the biosciences. A co-venture between Duke University, Harvard University Law School, and Stanford University, and published by Oxford University Press, this open access, online, and interdisciplinary academic journal publishes cutting-edge scholarship in this important new field. The Journal contains original and response articles, essays, and commentaries on a wide range of topics, including bioethics, neuroethics, genetics, reproductive technologies, stem cells, enhancement, patent law, and food and drug regulation. JLB is published as one volume with three issues per year with new articles posted online on an ongoing basis.